Carvykti Euroopan unioni - sloveeni - EMA (European Medicines Agency)

carvykti

janssen-cilag international nv - ciltacabtagene autoleucel - multiple myeloma - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Tecvayli Euroopan unioni - sloveeni - EMA (European Medicines Agency)

tecvayli

janssen-cilag international n.v. - teclistamab - multiple myeloma - antineoplastična sredstva - tecvayli is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Akeega Euroopan unioni - sloveeni - EMA (European Medicines Agency)

akeega

janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - prostatic neoplazem, kastracija-odporne - antineoplastična sredstva - treatment of adult patients with prostate cancer.

Talvey Euroopan unioni - sloveeni - EMA (European Medicines Agency)

talvey

janssen-cilag international n.v. - talquetamab - multiple myeloma - antineoplastična sredstva - talvey is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least 3 prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti cd38 antibody and have demonstrated disease progression on the last therapy.

DARZALEX 20 mg/ml koncentrat za raztopino za infundiranje Slovenia - sloveeni - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

darzalex 20 mg/ml koncentrat za raztopino za infundiranje

janssen-cilag international nv - koncentrat za raztopino za infundiranje - daratumumab

DARZALEX 20 mg/ml koncentrat za raztopino za infundiranje Slovenia - sloveeni - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

darzalex 20 mg/ml koncentrat za raztopino za infundiranje

janssen-cilag international nv - koncentrat za raztopino za infundiranje - daratumumab

STELARA 130 mg koncentrat za raztopino za infundiranje Slovenia - sloveeni - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

stelara 130 mg koncentrat za raztopino za infundiranje

janssen-cilag international nv - ustekinumab - koncentrat za raztopino za injiciranje - ustekinumab 130 mg / 1 viala - ustekinumab

VERMOX 100 mg tablete Slovenia - sloveeni - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

vermox 100 mg tablete

janssen-cilag kft. - mebendazol - tableta - mebendazol 100 mg / 1 tableta - mebendazol

ZYTIGA 500 mg filmsko obložene tablete Slovenia - sloveeni - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

zytiga 500 mg filmsko obložene tablete

janssen-cilag international nv - abirateronacetat - filmsko obložena tableta - abirateronacetat 500 mg / 1 tableta - abirateron

HYPNOMIDATE 2 mg/ml raztopina za injiciranje Slovenia - sloveeni - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

hypnomidate 2 mg/ml raztopina za injiciranje

janssen-cilag kft. - etomidat - raztopina za injiciranje - etomidat 2 mg / 1 ml - etomidat